Acronym
RESPIRNA
Code
41B04521
Duration
01 May 2021 → 30 April 2026
Funding
European funding: framework programme
Principal investigator


Research disciplines
-
Medical and health sciences
- Drug discovery and development not elsewhere classified
Keywords
therapeutics
Project description
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency (ERCEA). Neither the European Union nor the authority can be held responsible for them.